Stada - comment

Buying a generics business for €3bn seems a stretch unless Bain is willing to put a lot of equity into the deal. The new issue market is thawing, but the timeline would require a hard sell. A joint bid or a separate vehicle (to be merged later) seems more attainable given current market conditions.

https://au.finance.yahoo.com/news/advent-cvc-among-suitors-3-174248602.html